Urolithiasis Clinical Trial
— RISUS_AIOfficial title:
Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence
Kidney stone disease causes significant morbidity, and stones obstructing the ureter can have serious consequences. Imaging diagnostics with computed tomography (CT) are crucial for diagnosis, treatment selection, and follow-up. Segmentation of CT images can provide objective data on stone burden and signs of obstruction. Artificial intelligence (AI) can automate such segmentation but can also be used for the diagnosis of stone disease and obstruction. In this project, the aim is to investigate if: Manual segmentation of CT scans can provide more accurate information about kidney stone disease compared to conventional interpretation. AI segmentation yields valid results compared to manual segmentation. AI can detect ureteral stones and obstruction or predict spontaneous passage.
Status | Not yet recruiting |
Enrollment | 500 |
Est. completion date | March 28, 2028 |
Est. primary completion date | November 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Referral for CT due to episode of renal colic and clinical suspicion of urinary stone disease or - Referral for CT due to new episode of pain in patient with known urinary stone disease - Age = 18 years Exclusion Criteria: - Referral for control CT of asymptomatic patients with known urinary stone disease - Referral for control CT after treatment - Referral for control CT for spontaneous passage of stone. - Lack of informed consent for any reason. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Oslo University Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of stone diameter from manual segmentation with radiology report | Stone diameter (in mm) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Primary | Comparison of AI-segmentation of stones (DICE-score) with manual segmentation | DICE-score for AI-segmentation of stones, compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Primary | Prospective performance (diagnostic accuracy) of AI detection of ureteral stone (compared to radiology report (gold standard) | Comparison of differences in dicotomous proportions in paired data according to Newcombe | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of stone density from manual segmentation with radiology report | Stone density (in Hounsfield Units) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of distention of renal pelvis from manual segmentation with radiology report | Distention of renal pelvis (in mm) compared between manual segmentation and radiology report (paired t-test or wilcoxon rank sum test if non-normally distributed data) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of stones (Hausdorff distance) with manual segmentation | Haussdorff distance for AI-segmentation of stones, compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of stones (diagnostic accuracy) with manual segmentation | Diagnostic accuracy for AI-segmentation of stones compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of renal pelvis (Dice-score) with manual segmentation | DICE-score for AI-segmentation of renal pelvis compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of renal pelvis (Hausdorff distance) with manual segmentation | Hausdorff distance for AI-segmentation of renal pelvis compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of renal pelvis (diagnostic accuracy) with manual segmentation | Diagnostic accuracy for AI-segmentation of renal pelvis compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of renal parenchyma (DICE-score) with manual segmentation | DICE-score for AI-segmentation of renal parenchyma compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of renal parenchyma (Hausdorff distance) with manual segmentation | Hausdorff distance for AI-segmentation of renal parenchyma compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Comparison of AI-segmentation of renal parenchyma (diagnostic accuracy) with manual segmentation | Diagnostic accuracy for AI-segmentation of renal parenchyma compared to manual segmenation (gold standard) | At time of CT examination (inclusion and follow up - expected average 12 weeks) | |
Secondary | Prospective performance (diagnostic accuracy) of AI detection of ureteral obstruction (compared to radiology report (gold standard) | Comparison of differences in dicotomous proportions in paired data according to Newcombe | At time of CT examination (inclusion and follow up - expected average 12 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04021381 -
Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi
|
Phase 3 | |
Completed |
NCT02266381 -
A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy
|
N/A | |
Terminated |
NCT01431378 -
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
|
N/A | |
Completed |
NCT01451931 -
Study of Tomography of Nephrolithiasis Evaluation
|
Phase 4 | |
Completed |
NCT02895711 -
Radiation Dose of Pediatric Patients During Ureteroscopy
|
||
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Completed |
NCT05340075 -
Staged Bilateral Percutaneous Nephrolithotomy
|
||
Recruiting |
NCT03919227 -
Measurement of Resistance During UAS Insertion Procedure in RIRS
|
N/A | |
Recruiting |
NCT03717285 -
Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
|
N/A | |
Completed |
NCT05340088 -
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
|
||
Completed |
NCT05032287 -
Medical Expulsive Therapy Post-SWL For Renal Stones
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT04080973 -
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
|
N/A | |
Terminated |
NCT01736358 -
The Use of Intranasal Ketoralac for Pain Management (Sprix)
|
Phase 4 | |
Completed |
NCT01792765 -
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
|
N/A | |
Completed |
NCT06211842 -
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Not yet recruiting |
NCT04606758 -
Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease
|
N/A |